Jane C. McDonald, MD

Primary Axis: 
Infection and Immunity
Research Focus: 

Research is focused on clinical trials related to prevention of serious respiratory infections in high risk infants with monoclonal antibodies. Involved with the Montreal Childrens Hospital Vaccine Study Center as investigator for new formulations of vaccines for the prevention of meningococcal and pneumococcal infections. Research interest in rapid viral diagnostics.Pediatric respiratory infections, Rapid viral diagnostics, Vaccine trials

Keywords: 
Pediatric respiratory infections, Rapid viral diagnostics, Vaccine trials
Location: 
Montreal Children's Hospital
Publications:
Vinh D, Newby D, Charest H, McDonald J. Evaluation of a Commercial Direct Fluorescent-Antibody Assay for Human Metapneumovirus in Respiratory Specimens. Journal of Clinical Microbiology 46: 1840-1841; 2008.
Baz M, Abed Y, McDonald J, Boivin G. Characterization of Multi-Drug-Resistant Influenza A/H3N2 Viruses Shed during 1 Year by an Immunocompromised Child. Clinical Infectious Diseases 43: 1555-1561; 2006.
Halperin S, McDonald J, Samson L, et. al. Simultaneous Administration of a Meningococcal C Conjugate vaccine and Diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type B Conjugate Vaccine in Children: a Double-blind Randomization Study. Clinical and Investigative Medicine 25: 243-251; 2002.